These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35473688)

  • 1. Egyptian revalidation of non-invasive parameters for predicting esophageal varices in cirrhotic patients: A retrospective study.
    El-Kassas M; Elakel W; Alboraie M; Ezzat R; Abdelhakam S; Hassany M; Ali-Eldin Z; Sherief AF; Yosry A; El-Serafy M; El-Sayed MH; Waked I; Doss W; Esmat G;
    Arab J Gastroenterol; 2022 May; 23(2):120-124. PubMed ID: 35473688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
    Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
    Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for esophageal varices in cirrhotic patients - Non-invasive methods.
    Mattos ÂZ; Schacher FC; John Neto G; Mattos AA
    Ann Hepatol; 2019; 18(5):673-678. PubMed ID: 31279653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the EVendo score for the prediction of varices in cirrhotic patients.
    Alswat K; Alanazi M; Bashmail A; Alkhamash M; Alqahtani SA; Al-Hamoudi W; Abdo AA
    Saudi J Gastroenterol; 2022; 28(5):378-384. PubMed ID: 35229755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baveno criteria perform better than expanded Baveno and Rete Sicilia Selezione Terapia-Hepatitis C virus criteria for predicting varices needing treatment.
    Agarwal A; Pathak P; Gupta S; Kumar R; Shalimar
    Indian J Gastroenterol; 2021 Dec; 40(6):590-597. PubMed ID: 33991311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Noninvasive assessment of the risk of esophageal variceal bleeding from noncirrhotic portal hypertension].
    Xu HF; Wang Y; He FL; Fan ZH; Liu H; Yang YP; Jia JD; Liu FQ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1092-1099. PubMed ID: 36727234
    [No Abstract]   [Full Text] [Related]  

  • 10. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive diagnosis of esophageal varices after Baveno VI.
    Moctezuma Velázquez C; Abraldes JG
    Turk J Gastroenterol; 2017 May; 28(3):159-165. PubMed ID: 28492370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients?
    Hassan EM; Omran DA; El Beshlawey ML; Abdo M; El Askary A
    Gastroenterol Hepatol; 2014 Feb; 37(2):58-65. PubMed ID: 24365388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
    Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
    J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
    Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
    Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
    Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
    J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
    Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
    Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
    Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
    Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis.
    Ahmed S; Sharma S; Agarwal S; Wong YJ; Putera M; Saraya A
    Indian J Gastroenterol; 2024 Jun; 43(3):609-615. PubMed ID: 37840111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding.
    Marot A; Trépo E; Doerig C; Schoepfer A; Moreno C; Deltenre P
    Liver Int; 2017 May; 37(5):707-716. PubMed ID: 27862856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.